Annovis Bio, Inc. (ANVS)
1.92
+0.02
(+1.05%)
USD |
NYSE |
May 29, 16:00
1.97
+0.05
(+2.60%)
After-Hours: 20:00
Annovis Bio Total Liabilities (Quarterly) : 13.12M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 270.36M |
| Gain Therapeutics, Inc. | 4.732M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Anika Therapeutics, Inc. | 45.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.24M |
| Shareholders Equity (Quarterly) | 3.126M |
| Current Ratio | 1.27 |